RudaCure held its à l'échelle de l'entreprise New Year ceremony at the Seoul office on the first Monday of January 2025.
At the ceremony, le PDG Yongho Kim declared preparations for IPO and presented goals notamment system reorganization for IPO, technology advancement, successful progression of ongoing RCI001 essais cliniques to the next phase, transfert de technologie through non clinique toxicity studies for pain drug RCI002, and successful PoC for pharmaceutique vétérinaire RCI001AH.
Celebrating the 7th anniversary of de l'entreprise founding in 2025, the team celebrated the promotion of Adjoint au responsable Young-ah Ku to Manager and staff member Dongho Kwak to Adjoint au responsable. For remarquable results over the past year, Seunghyuk Choi was awarded as Employé méritant, and Adjoint au responsable Chanhee Choi a été sélectionnée comme Employé exemplaire for exemplary conduct.
Nous souhaitons à tous les employés de RudaCure une année 2025 filled with great achievements and hope it will be a year of meaningful growth.
